Adage Capital Partners Gp, L.L.C. Argenx Se Transaction History

Adage Capital Partners Gp, L.L.C.

$56.4 Billion
Q2 2025

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Argenx Se stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 297,113 shares of ARGX stock, worth $237 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

297,113

Previous 138,637 114.31%

Holding current value

$237 Million

Previous $82.1 Million 99.59%

% of portfolio

0.29%

Previous 0.16%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$532.27 - $656.65 $84.4 Million - $104 Million	158,476 Added 114.31%	297,113 $164 Million
Q1 2025 May 15, 2025	BUY	$571.0 - $671.75 $27.9 Million - $32.8 Million	48,850 Added 54.41%	138,637 $82.1 Million
Q4 2024 Feb 14, 2025	SELL	$520.52 - $638.33 $41.1 Million - $50.4 Million	-79,000 Reduced 46.8%	89,787 $55.2 Million
Q3 2024 Nov 14, 2024	BUY	$434.22 - $551.9 $27 Million - $34.4 Million	62,280 Added 58.48%	168,787 $91.5 Million
Q2 2024 Aug 14, 2024	BUY	$356.01 - $451.55 $37.9 Million - $48.1 Million	106,507 New	106,507 $45.8 Million
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $1.02 Million - $1.52 Million	3,000 Added 2.83%	108,951 $41.4 Million
Q3 2023 Nov 14, 2023	SELL	$369.35 - $548.43 $17.3 Million - $25.7 Million	-46,845 Reduced 30.66%	105,951 $52.1 Million
Q2 2023 Aug 14, 2023	SELL	$360.14 - $422.58 $66.1 Million - $77.6 Million	-183,600 Reduced 54.58%	152,796 $59.5 Million
Q1 2023 May 15, 2023	BUY	$334.23 - $403.65 $16.4 Million - $19.8 Million	49,000 Added 17.05%	336,396 $125 Million
Q4 2022 Feb 14, 2023	BUY	$342.17 - $402.31 $98.3 Million - $116 Million	287,396 New	287,396 $109 Million
Q1 2021 May 17, 2021	SELL	$268.3 - $380.31 $9.39 Million - $13.3 Million	-35,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$248.13 - $308.36 $2.48 Million - $3.08 Million	10,000 Added 40.0%	35,000 $10.3 Million
Q3 2020 Nov 16, 2020	BUY	$215.51 - $272.51 $5.39 Million - $6.81 Million	25,000 New	25,000 $6.56 Million
Q4 2018 Feb 14, 2019	SELL	$63.81 - $109.82 $64.8 Million - $112 Million	-1,015,981 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$75.5 - $96.63 $36.9 Million - $47.3 Million	-489,019 Reduced 32.49%	1,015,981 $77.1 Million
Q2 2018 Aug 14, 2018	BUY	$74.84 - $100.16 $41.6 Million - $55.6 Million	555,500 Added 58.5%	1,505,000 $125 Million
Q1 2018 May 15, 2018	BUY	$56.95 - $85.19 $11.1 Million - $16.6 Million	194,500 Added 25.76%	949,500 $76.4 Million
Q4 2017 Feb 14, 2018	BUY	$22.57 - $63.56 $13.7 Million - $38.5 Million	605,000 Added 403.33%	755,000 $47.7 Million
Q3 2017 Nov 14, 2017	BUY	$19.81 - $22.61 $2.97 Million - $3.39 Million	150,000	150,000 $3.39 Million

Others Institutions Holding ARGX

# of Institutions

491

Shares Held

28.3M

Call Options Held

370K

Put Options Held

211K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $44.1B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Argenx Se Transaction History